Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment
| Autor: | Xiao-xia Fu, Wen-jian Xiao, Jian Lu, Fan Yang, Le-wen Wu |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Myocardial Infarction Electrocardiography Internal medicine medicine Retrospective analysis Creatine Kinase MB Form Humans Thrombolytic Therapy Pharmacology (medical) cardiovascular diseases Myocardial infarction Retrospective Studies business.industry Electrocardiography in myocardial infarction Heart General Medicine Thrombolysis Middle Aged medicine.disease Urokinase-Type Plasminogen Activator Clinical trial Integrative therapy Complementary and alternative medicine Elevated st segment Medicine public health cardiovascular system Cardiology Female business Drugs Chinese Herbal |
| Zdroj: | Chinese Journal of Integrative Medicine. 15:462-465 |
| ISSN: | 1993-0402 1672-0415 |
| Popis: | To explore the cardiac protective effect of integrative therapy in acute myocardial infarction (AMI) with elevated ST segment after reperfusion.Sixty-four AMI patients who having received decimalization by thrombolysis were assigned to two groups by retrospective analysis, 36 patients in the treated group and 28 in the control group. Both were treated by intravenous administering of urokinase for thrombolysis, and to the treated group, intravenous dripping of Xueshuantong Injection (, XST) was added. Serum levels of myocardial associated enzymes were monitored before treatment and at various time points after thrombolysis, and the heart function parameters were detected with color echocardiography before treatment and on the 7th and 14th day of treatment. The patients were followed up for 6 months to observe the incidence of cardiac events.The differences between groups at the peak and peak appearing time of creatine kinase and creatine kinase isoenzyme were not significant. All the heart function parameters on the 7th and 14th day in the treated group were improved and superior to those at the corresponding time points in the control group (P0.05, P0.01). Incidence of some heart events in the treated group within the 6-month follow-up period was lesser than that in the control group (P0.05).XST Injection could provide effective protection for the heart after reperfusion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink